2024
Alcohol use, alcohol use disorder and heavy episodic drinking in the Eastern Mediterranean region: A systematic review
Rostam‐Abadi Y, Gholami J, Shadloo B, Aghaei A, Jobehdar M, Ardeshir M, Sangchooli A, Amin‐Esmaeili M, Taj M, Saeed K, Rahimi‐Movaghar A. Alcohol use, alcohol use disorder and heavy episodic drinking in the Eastern Mediterranean region: A systematic review. Addiction 2024, 119: 984-997. PMID: 38356084, DOI: 10.1111/add.16444.Peer-Reviewed Original ResearchConceptsAdult general populationGeneral populationAlcohol useEastern Mediterranean RegionWorld Health OrganizationAlcohol use disorderPrevalence of alcohol use disordersYoung general populationHealth OrganizationEastern Mediterranean countriesPatterns of alcohol usePublic health impactUse disorderHeavy episodic drinkingEstimates of alcoholAlcohol consumptionPooled prevalencePooled estimatesSystematic reviewHealth impactsEpisodic drinkingHeavy drinkingSubstance useTreatment-seeking peoplePrevalence
2021
Public health risks associated with methadone in Iran: A systematic review and meta-analysis
Rostam-Abadi Y, Gholami J, Noroozi A, Ansari M, Baheshmat S, Hamzehzadeh M, Ghadirzadeh M, Vahdani B, Ekhtiari H, Mojtabai R, Rahimi-Movaghar A. Public health risks associated with methadone in Iran: A systematic review and meta-analysis. International Journal Of Drug Policy 2021, 100: 103529. PMID: 34826790, DOI: 10.1016/j.drugpo.2021.103529.Peer-Reviewed Original ResearchConceptsMethadone maintenance treatmentNon-prescribed useMethadone useSystematic reviewGeneral populationPositive health outcomesUse disorderFemale general populationSystematic review of studiesSixty-five studiesRandom-effects modelLegal Medicine OrganizationMethadone maintenance treatment programsPublic health concernHealth outcomesSubstance-related deathsReview of studiesPooled proportionCases of acute poisoningMaintenance treatmentMedicine organizationsDrug treatment centersIranian databasesAdverse outcomesPrescription opioidsHIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis
Gholami J, Rostam‐Abadi Y, Rahimi Y, Fotouhi A, Amin‐Esmaeili M, Rahimi‐Movaghar A. HIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis. Drug And Alcohol Review 2021, 41: 666-676. PMID: 34783411, DOI: 10.1111/dar.13407.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus prevalenceHuman immunodeficiency virusOdds of HIV infectionHIV infectionSystematic reviewPrevalence of human immunodeficiency virusPrevalence of HIV infectionReduce HIV prevalenceRandom-effects modelCitation trackingHIV prevalenceImmunodeficiency virusNo significant differenceHarm reductionPWUDGeneral populationUnpublished studiesGender subgroupsComprehensive searchNational databaseMeta-analysisSignificant differencePrevalencePreventive measuresInfectionEvidence for an increase in cannabis use in Iran – A systematic review and trend analysis
Rostam-Abadi Y, Gholami J, Amin-Esmaeili M, Baheshmat S, Hamzehzadeh M, Rafiemanesh H, Nasserbakht M, Ghalichi L, Safarcherati A, Taremian F, Mojtabai R, Rahimi-Movaghar A. Evidence for an increase in cannabis use in Iran – A systematic review and trend analysis. PLOS ONE 2021, 16: e0256563. PMID: 34460847, PMCID: PMC8404985, DOI: 10.1371/journal.pone.0256563.Peer-Reviewed Original ResearchConceptsCannabis use disorderCannabis useUse disorderPrevalence of cannabis use disorderTrends of cannabis usePrevalence of cannabis useGeneral populationPrevalence estimatesHigh-risk groupIranian general populationRandom-effects modelPooled prevalence estimatePooled prevalenceYouth groupsCannabisA systematic reviewSex subgroupsIllicit substancesIranian databasesPrevalenceSystematic reviewNational studyFemale university studentsDisordersMaleBuprenorphine abuse and health risks in Iran: A systematic review
Ansari M, Rostam-Abadi Y, Baheshmat S, Hamzehzadeh M, Gholami J, Mojtabai R, Rahimi-Movaghar A. Buprenorphine abuse and health risks in Iran: A systematic review. Drug And Alcohol Dependence 2021, 226: 108871. PMID: 34214882, DOI: 10.1016/j.drugalcdep.2021.108871.Peer-Reviewed Original ResearchConceptsBuprenorphine maintenance treatmentSystematic reviewPrevalence of non-prescribed useNon-prescribed useInternational electronic databasesBuprenorphine poisoningCompared to other opioidsBuprenorphine useElectronic databasesPoisoning casesIdentified recordsDrug poisoning casesIranian databasesGeneral populationEligibility criteriaTreatment-seekingNational studyRegular useNon-prescribed buprenorphine useMaintenance treatmentBuprenorphineHealth risksBuprenorphine abusePrevalenceRelevant data
2020
Tramadol use and public health consequences in Iran: a systematic review and meta‐analysis
Rostam‐Abadi Y, Gholami J, Amin‐Esmaeili M, Safarcherati A, Mojtabai R, Ghadirzadeh M, Rahimi H, Rahimi‐Movaghar A. Tramadol use and public health consequences in Iran: a systematic review and meta‐analysis. Addiction 2020, 115: 2213-2242. PMID: 32196801, DOI: 10.1111/add.15059.Peer-Reviewed Original ResearchConceptsPooled estimatesSystematic reviewConsistent with Preferred Reporting ItemsPrevalence of non-prescribed useIranian general populationPreferred Reporting ItemsPublic health challengeSystematically review studiesRandom-effects modelPrevalence of tramadol useMisuse of tramadolPublic health consequencesReporting ItemsHealth challengesPrescription analgesicsGeneral populationHealth consequencesHeterogeneous reportingFemale university studentsTramadol-related deathsMeta-analysisTramadol useSubgroups of malesNon-prescribed usePooled percentage